Tomo Osako

Researcher Name Resolver ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 16

Top Topics

Dna Damage Response

Positive Breast Cancer

Top Venues

British journal of cancer

Journal of medical case reports

This page only lists publications with an associated author ORCID identifier.

Publications

Kohei Kumegawa, Sumito Saeki, Yoko Takahashi, Liying Yang, Tomo Osako, Tomoyoshi Nakadai, Sayuri Amino, Tetsuyo Maeda, Chikako Takahata, Seiichi Mori, Tetsuo Noda, Shinji Ohno, Takayuki Ueno, Reo Maruyama
Correction: Chromatin profile-based identification of a novel ER-positive breast cancer subgroup with reduced ER-responsive element accessibility. British journal of cancer (2023)
Kohei Kumegawa, Sumito Saeki, Yoko Takahashi, Liying Yang, Tomo Osako, Tomoyoshi Nakadai, Sayuri Amino, Tetsuyo Maeda, Chikako Takahata, Seiichi Mori, Tetsuo Noda, Shinji Ohno, Takayuki Ueno, Reo Maruyama
Chromatin profile-based identification of a novel ER-positive breast cancer subgroup with reduced ER-responsive element accessibility. British journal of cancer (2023)
Kohei Kumegawa, Sumito Saeki, Yoko Takahashi, Liying Yang, Tomo Osako, Tomoyoshi Nakadai, Sayuri Amino, Tetsuyo Maeda, Chikako Takahata, Seiichi Mori, Tetsuo Noda, Shinji Ohno, Takayuki Ueno, Reo Maruyama
Chromatin profile-based identification of a novel ER-positive breast cancer subgroup with reduced ER-responsive element accessibility. British journal of cancer (2023)
Kohei Kumegawa, Sumito Saeki, Yoko Takahashi, Liying Yang, Tomo Osako, Tomoyoshi Nakadai, Sayuri Amino, Tetsuyo Maeda, Chikako Takahata, Seiichi Mori, Tetsuo Noda, Shinji Ohno, Takayuki Ueno, Reo Maruyama
Chromatin profile-based identification of a novel ER-positive breast cancer subgroup with reduced ER-responsive element accessibility. British journal of cancer (2023)
Kohei Kumegawa, Sumito Saeki, Yoko Takahashi, Liying Yang, Tomo Osako, Tomoyoshi Nakadai, Sayuri Amino, Tetsuyo Maeda, Chikako Takahata, Seiichi Mori, Tetsuo Noda, Shinji Ohno, Takayuki Ueno, Reo Maruyama
Correction: Chromatin profile-based identification of a novel ER-positive breast cancer subgroup with reduced ER-responsive element accessibility. British journal of cancer (2023)
Kohei Kumegawa, Sumito Saeki, Yoko Takahashi, Liying Yang, Tomo Osako, Tomoyoshi Nakadai, Sayuri Amino, Tetsuyo Maeda, Chikako Takahata, Seiichi Mori, Tetsuo Noda, Shinji Ohno, Takayuki Ueno, Reo Maruyama
Chromatin profile-based identification of a novel ER-positive breast cancer subgroup with reduced ER-responsive element accessibility. British journal of cancer (2023)
Megumi Fukuoka, Yuichi Ichikawa, Tomo Osako, Tomoko Fujita, Satoko Baba, Kengo Takeuchi, Nobuyuki Tsunoda, Tomoki Ebata, Takayuki Ueno, Shinji Ohno, Noriko Saitoh
The ELEANOR noncoding RNA expression contributes to cancer dormancy and predicts late recurrence of estrogen receptor-positive breast cancer. Cancer science 113 (7) (2022)
Kohei Kumegawa, Yoko Takahashi, Sumito Saeki, Liying Yang, Tomoyoshi Nakadai, Tomo Osako, Seiichi Mori, Tetsuo Noda, Sumito Saeki, Takayuki Ueno, Reo Maruyama
GRHL2 motif is associated with intratumor heterogeneity of cis-regulatory elements in luminal breast cancer. NPJ breast cancer 8 (1) (2022)
Tomo Osako, Masaaki Matsuura, Daisuke Yotsumoto, Shin Takayama, Koji Kaneko, Mina Takahashi, Kenzo Shimazu, Katsuhide Yoshidome, Kazuya Kuraoka, Masayuki Itakura, Mayumi Tani, Takashi Ishikawa, Yasuyo Ohi, Takayuki Kinoshita, Nobuaki Sato, Masahiko Tsujimoto, Seigo Nakamura, Hitoshi Tsuda, Shinzaburo Noguchi, Futoshi Akiyama
A prediction model for early systemic recurrence in breast cancer using a molecular diagnostic analysis of sentinel lymph nodes: A large-scale, multicenter cohort study. Cancer 128 (10) (2022)
Tomo Osako, Masaaki Matsuura, Hitoshi Tsuda, Shinzaburo Noguchi
Reply to "Survival analysis in a prediction model for early systemic recurrence in breast cancer". Cancer 128 (20) (2022)
Yurina Maeshima, Tomo Osako, Hidetomo Morizono, Mayu Yunokawa, Yumi Miyagi, Mari Kikuchi, Takayuki Ueno, Shinji Ohno, Futoshi Akiyama
Metastatic ovarian cancer spreading into mammary ducts mimicking an in situ component of primary breast cancer: a case report. Journal of medical case reports 15 (1) (2021)
Tomo Osako
How can we better distinguish metastatic tumors from primary tumors in the breast? Expert review of anticancer therapy 21 (9) (2021)
Masashi Akiya, Tomo Osako, Hidetomo Morizono, Noriyuki Furuta, Mari Kikuchi, Takayuki Ueno, Shinji Ohno, Kengo Takeuchi
Myofibroblastoma of the breast showing rare palisaded morphology and uncommon desmin- and CD34-negative immunophenotype: A case report. Pathology international 71 (8) (2021)
Reiko Yoshida, Taichi Hagio, Tomoko Kaneyasu, Osamu Gotoh, Tomo Osako, Norio Tanaka, Sayuri Amino, Noriko Yaguchi, Eri Nakashima, Dai Kitagawa, Takayuki Ueno, Shinji Ohno, Takeshi Nakajima, Seigo Nakamura, Yoshio Miki, Toru Hirota, Shunji Takahashi, Masaaki Matsuura, Tetsuo Noda, Seiichi Mori
Pathogenicity assessment of variants for breast cancer susceptibility genes based on BRCAness of tumor sample. Cancer science 112 (3) (2021)
Tomo Osako, Hakwoo Lee, Gulisa Turashvili, Derek Chiu, Steven McKinney, Stacey E P Joosten, Darcy Wilkinson, Torsten O Nielsen, Wilbert Zwart, Joanne T Emerman, Connie J Eaves, Carlos Caldas, Samuel A J R Aparicio
Age-correlated protein and transcript expression in breast cancer and normal breast tissues is dominated by host endocrine effects. Nature cancer 1 (5) (2020)
Rika Yonekura, Tomo Osako, Takuji Iwase, Akiko Ogiya, Takayuki Ueno, Masanobu Kitagawa, Shinji Ohno, Futoshi Akiyama
Prognostic impact and possible pathogenesis of lymph node metastasis in ductal carcinoma in situ of the breast. Breast cancer research and treatment 174 (1) (2018)